Merck 3Q Revenues: $11.5 billion (-4%)   3Q Earnings: $1.8 billion (+2%)   YTD Revenues: $35.5 billion (-1%)   YTD Earnings: $5.4 billion (+10%)   Comments: Pharmaceutical sales were down 5% to $9.9 billion, including a 5% negative impact from foreign exchange and the loss of market exclusivity for Singulair in the U.S. in August (-55% to $602 million). Januvia sales were up 15% to $975 million. Zetia sales were up 5% to $645 million. Gardasil sales were up 31% to $581 million. Janumet and Ise...